ProCE Banner Activity

New Biomarker Insights to Optimize Treatment Decisions for Patients With Lung Cancer

Slideset Download
In this downloadable slideset, Edward S. Kim, MD, FACP, explains how various biomarkers can be used to guide treatment of patients with lung cancer, including EGFR, ALK, ROS-1, BRAF, and PD-L1.

Released: June 08, 2018

Expiration: June 07, 2019

No longer available for credit.

Share

Faculty

Edward S. Kim

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

AbbVie

Agios Pharmaceuticals

Bayer Healthcare Pharma

Celgene TEXT Only

Foundation Medicine

Loxo Oncology

Merck Oncology

Faculty Disclosure

Primary Author

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas